Australia markets closed

Nascent Biotech, Inc. (NBIO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.0899-0.0001 (-0.11%)
At close: 01:10PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
-2,093
-2,801
-470.39
-958.767
-4,004
Stock-based compensation
923.403
684.32
116.085
785.852
1,104
Change in working capital
178.522
-317.335
911.176
-102.518
1,816
Accounts receivable
-
0
750
-750
-
Accounts payable
186.702
-245.519
167.06
230.401
327.028
Other working capital
-1,221
-1,787
413.479
-986.784
-554.325
Other non-cash items
663.166
1,630
325.431
86.662
59.935
Net cash provided by operating activities
-1,221
-1,787
413.479
-986.784
-554.325
Cash flows from financing activities
Debt repayment
-400
-275
-520
0
-
Common stock issued
-
-
-
-
115
Other financing activities
-
-
-0.5
-
-
Net cash used provided by (used for) financing activities
1,286
1,865
-320
985
426.071
Net change in cash
65.09
77.772
92.979
-1.783
-128.254
Cash at beginning of period
558.764
94.414
1.435
3.218
131.472
Cash at end of period
623.854
172.186
94.414
1.435
3.218
Free cash flow
Operating cash flow
-1,221
-1,787
413.479
-986.784
-554.325
Free cash flow
-1,221
-1,787
413.479
-986.784
-554.325